CBIO · Crescent Biopharma, Inc. · Share Buybacks
$13.94
-0.38 (-2.65%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$548.24M
Shares
37.14M
Volume · Oct 5
187.02K
Avg daily vol (3M)
380.11K
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-07-01 | — | $200,000,000 | — | — | 10-Q , filed 2026-07-30 |